EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melasma Revisited: National Survey Reveals How Dermatologists Diagnose and Treat This Complex Skin Condition

Pelin Hizli iD, Fatma Arzu Kiliç iD, Seyma İçöz Aytaç iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.16630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Pelin Hizli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Balikesir University, Balikesir, Turkiye. Hauptthemen laut MEDLINE: Melanosis, Dermatologists, Practice Patterns, Physicians'. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melasma is a chronic condition characterized by dark patches on the facial skin. It has a known female gender dominancy, and women usually think of melasma as being a serious cosmetic problem. Treatment of melasma can be seriously challenging, thus, dermatologists may employ different approaches for melasma. This study aimed to investigate how dermatologists diagnose and treat patients with melasma and to present the general characteristics of patients with melasma.

Methods

A survey was conducted using Google Forms targeting dermatologists in Turkiye. A total of 199 dermatologists (142 females/57 males) participated in the study.

Results

Most of the participants (52.3%) were residents. Majority gender of the patients was female and most common age range of patients with melasma was 30–40 years. Mixed melasma was the most common type (57.4%). Malar region was the most frequent location (58.6%). Wood's lamp examination was used by 25.6% of the participants. Topical treatment was the first‐line choice for melasma therapy (95%), with Kligman's formula being the most used topical agent (69.8%). Oral therapy was not used by 70.8% of the participants. Tranexamic acid was the first choice for oral treatment (23.4%). Only 24.9% of the dermatologists used laser/light therapy, and Q‐switched Nd‐YAG laser was the most preferred device (58%). The most common recurrence rate was 41%–60% (45.9%).

Conclusions

The findings of the current study investigating the melasma management in Turkiye revealed a female predominance and peak prevalence in the 30–40 years age group. Kligman's formula is the preferred topical treatment, whereas oral tranexamic acid remains underutilized. Recurrence rates are high, highlighting the need for preventative strategies. This study emphasizes the importance of personalized approaches and ongoing research for effective melasma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanosisDermatologistsPractice Patterns, Physicians'HumansFemaleAdultMaleMiddle AgedSurveys and QuestionnairesTranexamic AcidDermatologic AgentsAdministration, CutaneousHealth Care Surveys

Stichwörter der Autor:innen

chemical peelingdermatologistlasermelasmatranexamic acid

Substanzen

Tranexamic AcidDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Balikesir University, Balikesir, Turkiye.

ORCID-Profile: Pelin Hizli, Fatma Arzu Kiliç, Seyma İçöz Aytaç

Zitieren

APA

Hizli, P., Kiliç, F. A., & İçöz Aytaç, S. (2025). Melasma Revisited: National Survey Reveals How Dermatologists Diagnose and Treat This Complex Skin Condition. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16630

Vancouver

Hizli P, Kiliç FA, İçöz Aytaç S. Melasma Revisited: National Survey Reveals How Dermatologists Diagnose and Treat This Complex Skin Condition. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16630

BibTeX
@article{Hizli2025,
  author = {Hizli, Pelin and Kiliç, Fatma Arzu and İçöz Aytaç, Seyma},
  title = {Melasma Revisited: National Survey Reveals How Dermatologists Diagnose and Treat This Complex Skin Condition},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.16630}
}
Kostenlos starten →